Antihypertensive effect of spironolactone in essential, renal and mineralocorticoid hypertension.
D000328:Adult; D000450:Aldosterone / Q000652:urine; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000150:complications; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D006977:Hypertension, Renal / Q000188:drug therapy*; D007674:Kidney Diseases / Q000150:complications; D008297:Male; D008901:Mineralocorticoids / Q000097:blood*; D006899:Mixed Function Oxygenases / Q000097:blood; D011188:Potassium / Q000097:blood; D012083:Renin / Q000097:blood; D013148:Spironolactone / Q000008:administration & dosage / Q000627:therapeutic use*
D008901:Mineralocorticoids; D013148:Spironolactone; D000450:Aldosterone; D006899:Mixed Function Oxygenases; D012083:Renin; D011188:Potassium